Tyr88
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.5.9.3
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Tyr88  -  PXN iso2 (human)

Site Information
PQsssPVyGssAKTs   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 448909
Associated spectra:  3 CST

In vivo Characterization
Methods used to characterize site in vivo:
immunoprecipitation ( 166 ) , mass spectrometry ( 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 , 63 , 64 , 65 , 66 , 67 , 68 , 69 , 70 , 71 , 72 , 73 , 74 , 75 , 76 , 77 , 78 , 79 , 80 , 81 , 82 , 83 , 84 , 85 , 86 , 87 , 88 , 89 , 90 , 91 , 92 , 93 , 94 , 95 , 96 , 97 , 98 , 99 , 100 , 101 , 102 , 103 , 104 , 105 , 106 , 107 , 108 , 109 , 110 , 111 , 112 , 113 , 114 , 115 , 116 , 117 , 118 , 119 , 120 , 121 , 122 , 123 , 124 , 125 , 126 , 127 , 128 , 129 , 130 , 131 , 132 , 133 , 134 , 135 , 136 , 137 , 138 , 139 , 140 , 141 , 142 , 143 , 144 , 145 , 146 , 147 , 148 , 149 , 150 , 151 , 152 , 153 , 154 , 155 , 156 , 157 , 158 , 159 , 160 , 161 , 162 , 163 , 164 , 165 , 166 , 167 , 168 , 169 , 170 , 171 , 172 , 173 , 174 , 175 , 176 , 177 , 178 , 179 , 180 , 181 , 182 , 183 , 184 , 185 , 186 , 187 , 188 , 189 , 190 , 191 , 192 , 193 , 194 , 195 , 196 , 197 , 198 , 199 , 200 , 201 , 202 , 203 , 204 , 205 , 206 , 207 , 208 , 209 , 210 , 211 , 212 , 213 , 214 , 215 , 216 , 217 , 218 , 219 , 220 , 221 , 222 , 223 , 224 , 225 , 226 , 227 , 228 , 229 , 230 , 231 , 232 , 233 , 234 , 235 , 236 , 237 , 238 , 239 , 240 , 241 , 242 , 243 , 244 , 245 , 246 , 247 , 248 , 249 , 250 , 251 , 252 , 253 , 254 , 255 , 256 , 257 , 258 , 259 , 260 , 261 , 262 , 263 , 264 , 265 , 266 , 267 , 268 , 269 , 270 , 271 , 272 , 273 , 274 , 275 , 276 , 277 , 278 , 279 , 280 , 281 , 282 , 283 , 284 , 285 , 286 , 287 , 288 , 289 , 290 , 291 , 292 , 293 , 294 , 295 , 296 , 297 , 298 , 299 , 300 , 301 , 302 , 303 , 304 , 305 , 306 , 307 , 308 , 309 , 310 , 311 , 312 , 313 , 314 , 315 , 316 , 317 , 318 , 319 , 320 , 321 , 322 , 323 , 324 , 325 , 326 , 327 , 328 , 329 , 330 , 331 , 332 , 333 , 334 , 335 , 336 , 337 , 338 , 339 , 340 , 341 , 342 , 343 , 344 , 345 , 346 , 347 , 348 , 349 , 350 , 351 , 352 , 353 , 354 , 355 , 356 , 357 , 358 , 359 , 360 , 361 , 362 , 363 , 364 , 365 , 366 , 367 , 368 , 369 , 370 , 371 , 372 , 373 , 374 , 375 , 376 , 377 , 378 , 379 , 380 , 381 , 382 , 383 , 384 , 385 , 386 , 387 , 388 , 389 , 390 , 391 , 392 , 393 , 394 , 395 , 396 , 397 , 398 , 399 , 400 , 401 , 402 , 403 , 404 , 405 , 406 , 407 , 408 , 409 , 410 , 411 , 412 , 413 , 414 , 415 , 416 , 417 , 418 , 419 , 420 , 421 , 422 , 423 , 424 , 425 , 426 , 427 , 428 , 429 , 430 , 431 , 432 , 433 , 434 , 435 , 436 , 437 , 438 , 439 , 440 , 441 , 442 , 443 , 444 , 445 , 446 , 447 , 448 , 449 , 450 , 451 , 452 , 453 , 454 , 455 , 456 , 457 , 458 , 459 , 460 , 461 , 462 , 463 , 464 , 465 , 466 , 467 , 468 , 469 , 470 , 471 , 472 , 473 , 474 , 475 , 476 , 477 , 478 , 479 , 480 , 481 , 482 , 483 , 484 , 485 , 486 , 487 , 488 , 489 , 490 , 491 , 492 , 493 , 494 , 495 , 496 , 497 , 498 , 499 , 500 , 501 , 502 , 503 , 504 , 505 , 506 , 507 , 508 , 509 , 510 , 511 , 512 , 513 , 514 , 515 , 516 , 517 , 518 , 519 , 520 , 521 , 522 , 523 , 524 , 525 , 526 , 527 , 528 , 529 , 530 , 531 , 532 , 533 , 534 , 535 , 536 , 537 , 538 , 539 , 540 , 541 , 542 , 543 , 544 , 545 , 546 , 547 , 548 , 549 , 550 , 551 , 552 , 553 , 554 , 555 , 556 , 557 , 558 , 559 , 560 , 561 , 562 , 563 , 564 , 565 , 566 , 567 , 568 , 569 , 570 , 571 , 572 , 573 , 574 , 575 , 576 , 577 , 578 , 579 , 580 , 581 , 582 , 583 , 584 , 585 , 586 , 587 , 588 , 589 , 590 , 591 , 592 , 593 , 594 , 595 , 596 , 597 , 598 , 599 , 600 , 601 , 602 , 603 , 604 , 605 , 606 , 607 , 608 , 609 , 610 , 611 , 612 , 613 , 614 , 615 , 616 , 617 , 618 , 619 , 620 , 621 , 622 , 623 , 624 , 625 , 626 , 627 , 628 , 629 , 630 , 631 , 632 , 633 , 634 , 635 , 636 , 637 , 638 , 639 , 640 , 641 , 642 , 643 , 644 , 645 , 646 , 647 , 648 , 649 , 650 , 651 , 652 , 653 , 654 , 655 , 656 , 657 , 658 , 659 , 660 , 661 , 662 , 663 , 664 , 665 , 666 , 667 , 668 , 669 , 670 , 671 , 672 , 673 , 674 , 675 , 676 , 677 , 678 , 679 , 680 , 681 , 682 , 683 , 684 , 685 , 686 , 687 , 688 , 689 , 690 , 691 , 692 , 693 , 694 , 695 , 696 , 697 , 698 , 699 , 700 , 701 , 702 , 703 , 704 , 705 , 706 , 707 , 708 , 709 , 710 , 711 , 712 , 713 , 714 , 715 , 716 , 717 , 718 , 719 , 720 , 721 , 722 , 723 , 724 , 725 , 726 , 727 , 728 , 729 , 730 , 731 , 732 , 733 , 734 , 735 , 736 , 737 , 738 , 739 , 740 , 741 , 742 , 743 , 744 , 745 , 746 , 747 , 748 , 749 , 750 , 751 , 752 , 753 , 754 , 755 , 756 , 757 , 758 , 759 , 760 , 761 , 762 , 763 , 764 , 765 , 766 , 767 , 768 , 769 , 770 , 771 , 772 , 773 , 774 , 775 , 776 , 777 , 778 , 779 , 780 , 781 , 782 , 783 , 784 , 785 , 786 , 787 , 788 , 789 , 790 , 791 , 792 , 793 , 794 , 795 , 796 , 797 , 798 , 799 , 800 , 801 , 802 , 803 , 804 , 805 , 806 , 807 , 808 , 809 , 810 , 811 , 812 , 813 , 814 , 815 , 816 , 817 , 818 , 819 , 820 , 821 , 822 , 823 , 824 , 825 , 826 , 827 , 828 , 829 , 830 , 831 , 832 , 833 , 834 , 835 , 836 , 837 , 838 , 839 , 840 , 841 , 842 , 843 , 844 , 845 , 846 , 847 , 848 , 849 , 850 , 851 , 852 , 853 , 854 , 855 , 856 , 857 , 858 , 859 , 860 , 861 , 862 , 863 , 864 , 865 , 866 , 867 , 868 , 869 , 870 , 871 , 872 , 873 , 874 , 875 , 876 , 877 , 878 , 879 , 880 , 881 , 882 , 883 , 884 , 885 , 886 , 887 , 888 , 889 , 890 , 891 , 892 , 893 , 894 , 895 , 896 , 897 , 898 , 899 , 900 , 901 , 902 , 903 , 904 , 905 , 906 , 907 , 908 , 909 , 910 , 911 , 912 , 913 , 914 , 915 , 916 , 917 , 918 , 919 , 920 , 921 , 922 , 923 , 924 , 925 , 926 , 927 , 928 , 929 , 930 , 931 , 932 , 933 , 934 , 935 , 936 , 937 , 938 , 939 , 940 , 941 , 942 , 943 , 944 , 945 , 946 , 947 , 948 , 949 , 950 , 951 , 952 , 953 , 954 , 955 , 956 , 957 , 958 , 959 , 960 , 961 , 962 , 963 , 964 , 965 , 966 , 967 , 968 , 969 , 970 , 971 , 972 , 973 , 974 , 975 , 976 , 977 , 978 , 979 , 980 , 981 , 982 , 983 , 984 , 985 , 986 , 987 , 988 , 989 , 990 , 991 , 992 , 993 , 994 , 995 , 996 , 997 , 998 , 999 , 1000 , 1001 , 1002 , 1003 , 1004 , 1005 , 1006 , 1007 , 1008 , 1009 , 1010 , 1011 , 1012 , 1013 , 1014 , 1015 , 1016 , 1017 , 1018 , 1019 , 1020 , 1021 , 1022 , 1023 , 1024 , 1025 , 1026 , 1027 , 1028 , 1029 , 1030 , 1031 , 1032 , 1033 , 1034 , 1035 , 1036 , 1037 , 1038 , 1039 , 1040 , 1041 , 1042 , 1043 , 1044 , 1045 , 1046 , 1047 , 1048 , 1049 , 1050 , 1051 , 1052 , 1053 , 1054 , 1055 , 1056 , 1057 , 1058 , 1059 , 1060 , 1061 , 1062 , 1063 , 1064 , 1065 , 1066 , 1067 , 1068 , 1069 , 1070 , 1071 , 1072 , 1073 , 1074 , 1075 , 1076 , 1077 , 1078 , 1079 , 1080 , 1081 , 1082 , 1083 , 1084 , 1085 , 1086 , 1087 , 1088 , 1089 , 1090 , 1091 , 1092 , 1093 , 1094 , 1095 , 1096 , 1097 , 1098 , 1099 , 1100 , 1101 , 1102 , 1103 , 1104 , 1105 , 1106 , 1107 , 1108 , 1109 , 1110 , 1111 , 1112 , 1113 , 1114 , 1115 , 1116 , 1117 , 1118 , 1119 , 1120 , 1121 , 1122 , 1123 , 1124 , 1125 , 1126 , 1127 , 1128 , 1129 , 1130 , 1131 , 1132 , 1133 , 1134 , 1135 , 1136 , 1137 , 1138 , 1139 , 1140 , 1141 , 1142 , 1143 , 1144 , 1145 , 1146 , 1147 , 1148 , 1149 , 1150 , 1151 , 1152 , 1153 , 1154 , 1155 , 1156 , 1157 , 1158 , 1159 , 1160 , 1161 , 1162 , 1163 , 1164 , 1165 , 1166 , 1167 , 1168 ) , mutation of modification site ( 166 ) , phospho-antibody ( 166 , 1079 ) , western blotting ( 166 )
Disease tissue studied:
atrial fibrillation ( 555 , 565 ) , adenoid cystic carcinoma ( 447 , 449 ) , bile-duct cancer ( 406 , 409 , 410 , 411 , 431 , 474 , 476 ) , bladder cancer ( 236 , 754 , 755 , 757 , 758 , 806 , 837 ) , bone cancer ( 622 , 623 , 624 , 650 , 651 , 652 , 653 , 1091 ) , Ewing's sarcoma ( 651 ) , osteosarcoma ( 622 , 623 , 624 , 650 , 652 , 653 , 1091 ) , brain cancer ( 38 , 39 , 50 , 202 , 203 , 204 , 205 , 421 , 479 , 486 , 487 , 498 , 499 , 584 , 585 , 607 , 656 , 667 , 669 , 670 , 768 , 831 , 832 , 836 , 866 , 905 , 906 , 921 , 925 , 926 , 927 , 930 , 931 , 933 , 934 , 935 , 936 , 937 , 941 , 942 , 949 , 953 , 954 , 955 , 962 , 974 , 975 , 993 , 1045 , 1046 , 1066 ) , astrocytoma ( 38 , 39 , 50 , 421 , 479 , 656 , 832 , 941 , 949 , 962 , 1045 , 1066 ) , glioblastoma ( 202 , 203 , 204 , 205 , 656 , 768 , 831 , 866 , 905 , 906 , 921 , 925 , 930 , 931 , 934 , 935 , 936 , 937 , 953 , 954 , 955 , 974 , 975 , 993 , 1046 ) , glioblastoma multiforme ( 486 , 487 , 498 , 499 , 584 , 585 , 607 , 656 , 667 , 669 , 670 , 831 , 866 , 921 , 925 , 931 , 954 , 974 , 975 ) , glioma ( 202 , 203 , 204 , 205 , 486 , 487 , 498 , 499 , 584 , 585 , 607 , 656 , 667 , 669 , 670 , 768 , 831 , 836 , 866 , 905 , 906 , 921 , 925 , 930 , 931 , 934 , 935 , 936 , 937 , 953 , 954 , 955 , 974 , 975 , 993 , 1046 ) , oligodendroglioma ( 927 ) , breast cancer ( 232 , 234 , 235 , 317 , 318 , 529 , 530 , 531 , 532 , 533 , 534 , 535 , 536 , 537 , 538 , 539 , 540 , 541 , 542 , 543 , 544 , 545 , 546 , 556 , 557 , 601 , 605 , 671 , 672 , 673 , 674 , 675 , 676 , 677 , 678 , 747 , 748 , 776 , 777 , 778 , 779 , 780 , 781 , 782 , 783 , 784 , 785 , 786 , 787 , 793 , 802 , 803 , 807 , 808 , 814 , 838 , 844 , 845 , 852 , 853 , 858 , 861 , 952 , 963 , 966 , 967 , 976 , 1034 , 1035 , 1036 , 1041 , 1042 , 1043 , 1044 , 1085 , 1086 , 1101 , 1102 , 1159 , 1160 , 1161 , 1162 , 1163 , 1164 ) , breast adenocarcinoma ( 802 , 858 , 966 , 1035 , 1036 , 1043 , 1044 , 1159 , 1160 , 1161 , 1162 , 1163 , 1164 ) , breast ductal carcinoma ( 952 , 967 , 1034 ) , breast cancer, surrounding tissue ( 232 , 234 , 235 ) , breast cancer, triple negative ( 780 , 781 , 782 , 783 , 963 , 967 , 976 ) , colorectal cancer ( 34 , 35 , 46 , 47 , 77 , 166 , 617 , 618 , 619 , 620 , 621 , 712 , 739 , 816 , 823 , 863 , 864 , 867 , 868 , 895 , 896 , 897 , 898 , 919 , 920 , 970 , 1013 , 1014 , 1024 , 1064 , 1065 , 1069 , 1070 , 1119 , 1120 , 1129 , 1130 , 1131 , 1132 , 1133 , 1136 , 1137 ) , colorectal carcinoma ( 34 , 35 , 46 , 47 , 166 , 617 , 618 , 619 , 620 , 621 , 712 , 739 , 816 , 823 , 863 , 864 , 867 , 868 , 895 , 896 , 897 , 898 , 919 , 920 , 970 , 1013 , 1014 , 1024 , 1064 , 1065 , 1069 , 1070 , 1119 , 1120 , 1129 , 1130 , 1131 , 1132 , 1133 , 1136 , 1137 ) , colorectal cancer, surrounding tissue ( 75 , 76 , 94 , 133 , 386 , 523 ) , esophageal cancer ( 145 , 146 , 147 , 148 , 149 , 150 , 151 , 152 , 153 , 311 , 312 , 315 , 322 , 324 , 325 , 326 , 327 , 336 , 338 , 341 , 343 , 344 , 346 , 347 , 350 , 796 , 797 , 824 , 825 , 826 , 827 , 828 , 839 , 840 , 841 , 842 , 843 , 894 , 902 , 903 , 904 , 908 , 909 , 910 , 911 , 912 , 913 ) , esophageal carcinoma ( 145 , 146 , 147 , 148 , 149 , 151 , 152 , 796 , 797 , 828 , 839 , 840 , 843 , 908 , 909 , 910 , 911 , 912 ) , esophageal cancer, surrounding tissue ( 323 , 328 , 329 , 330 , 331 , 332 , 333 , 334 , 335 , 337 , 339 , 340 , 342 , 345 , 348 ) , gallbladder cancer ( 430 , 481 ) , gallbladder carcinoma ( 481 ) , gastric cancer ( 1 , 2 , 4 , 5 , 6 , 7 , 23 , 24 , 25 , 26 , 27 , 36 , 37 , 48 , 49 , 105 , 119 , 120 , 121 , 122 , 170 , 173 , 185 , 210 , 212 , 214 , 215 , 216 , 217 , 218 , 219 , 221 , 222 , 224 , 459 , 462 , 466 , 549 , 551 , 552 , 562 , 566 , 572 , 574 , 576 , 578 , 579 , 580 , 581 , 582 , 583 , 589 , 596 , 597 , 598 , 599 , 600 , 709 , 711 , 794 , 865 , 869 ) , gastric carcinoma ( 1 , 2 , 4 , 5 , 6 , 7 , 23 , 24 , 25 , 26 , 27 , 36 , 37 , 48 , 49 , 105 , 119 , 120 , 121 , 122 , 173 , 185 , 459 , 462 , 549 , 551 , 552 , 566 , 572 , 574 , 576 , 582 , 709 , 711 , 865 ) , gastric carcinoma, surrounding tissue ( 211 , 220 , 223 , 458 , 460 , 461 , 464 , 465 , 467 , 468 , 548 , 550 , 561 , 563 , 564 , 573 , 575 , 590 ) , kidney cancer ( 242 , 243 , 252 , 625 , 626 , 753 , 804 ) , kidney cancer, surrounding tissue ( 237 , 244 , 253 ) , leukemia ( 72 , 116 , 117 , 158 , 160 , 172 , 188 , 189 , 190 , 206 , 233 , 396 , 553 , 588 , 646 , 647 , 649 , 654 , 655 , 694 , 695 , 696 , 710 , 714 , 801 , 877 , 888 , 889 , 892 , 893 , 899 , 900 , 901 , 957 , 958 , 959 , 960 , 961 , 985 , 997 , 1010 , 1025 , 1026 , 1047 , 1055 , 1084 , 1153 , 1166 ) , acute lymphocytic leukemia ( 801 , 1047 ) , acute myelogenous leukemia ( 877 , 985 , 1010 , 1025 , 1026 , 1055 ) , chronic myelogenous leukemia ( 72 , 116 , 117 , 158 , 160 , 172 , 188 , 189 , 190 , 206 , 233 , 396 , 553 , 588 , 649 , 654 , 655 , 694 , 695 , 696 , 710 , 714 , 888 , 889 , 892 , 893 , 899 , 900 , 901 , 957 , 958 , 959 , 960 , 961 , 997 , 1084 , 1153 , 1166 ) , liver cancer ( 73 , 139 , 256 , 258 , 266 , 267 , 268 , 271 , 272 , 277 , 278 , 281 , 282 , 285 , 287 , 288 , 292 , 295 , 296 , 301 , 303 , 304 , 355 , 356 , 359 , 360 , 364 , 366 , 369 , 370 , 371 , 372 , 373 , 385 , 405 , 408 , 423 , 424 , 427 , 428 , 429 , 432 , 480 , 482 , 483 , 484 , 485 , 510 , 514 , 547 , 592 , 594 ) , liver adenocarcinoma ( 356 , 547 ) , cholangiocellular carcinoma ( 73 , 385 , 480 , 514 , 592 ) , cholangiocellular carcinoma, surrounding tissue ( 265 , 383 , 516 ) , hepatocellular carcinoma ( 256 , 258 , 266 , 267 , 268 , 271 , 272 , 277 , 278 , 281 , 282 , 285 , 287 , 288 , 292 , 295 , 296 , 301 , 303 , 304 , 359 , 360 , 366 , 370 , 372 , 373 , 483 , 510 , 594 ) , hepatocellular carcinoma, surrounding tissue ( 255 , 257 , 259 , 269 , 270 , 273 , 274 , 275 , 276 , 279 , 280 , 283 , 284 , 286 , 289 , 290 , 293 , 294 , 298 , 300 , 302 , 361 , 362 , 363 , 365 , 367 , 368 , 384 , 513 , 515 , 593 , 595 ) , liver cancer, surrounding tissue ( 291 , 297 ) , lung cancer ( 28 , 29 , 30 , 31 , 32 , 33 , 40 , 41 , 42 , 43 , 44 , 45 , 51 , 53 , 62 , 112 , 167 , 185 , 197 , 199 , 305 , 308 , 309 , 310 , 313 , 314 , 316 , 357 , 358 , 374 , 375 , 387 , 388 , 389 , 390 , 391 , 392 , 393 , 394 , 418 , 419 , 422 , 436 , 437 , 443 , 463 , 469 , 470 , 471 , 472 , 495 , 496 , 509 , 527 , 528 , 558 , 559 , 560 , 567 , 568 , 569 , 570 , 571 , 611 , 612 , 613 , 657 , 658 , 659 , 679 , 680 , 681 , 682 , 683 , 684 , 685 , 686 , 687 , 691 , 692 , 704 , 705 , 706 , 707 , 708 , 715 , 716 , 717 , 718 , 719 , 720 , 721 , 722 , 723 , 724 , 725 , 726 , 727 , 728 , 729 , 730 , 731 , 732 , 733 , 734 , 735 , 736 , 737 , 738 , 740 , 741 , 742 , 756 , 759 , 760 , 764 , 784 , 785 , 795 , 809 , 810 , 811 , 812 , 813 , 815 , 829 , 830 , 847 , 848 , 849 , 851 , 854 , 855 , 856 , 857 , 859 , 860 , 862 , 873 , 874 , 875 , 878 , 885 , 887 , 914 , 915 , 916 , 917 , 922 , 923 , 924 , 928 , 929 , 932 , 938 , 939 , 940 , 943 , 944 , 946 , 947 , 948 , 950 , 951 , 956 , 968 , 971 , 977 , 978 , 979 , 980 , 986 , 987 , 988 , 989 , 990 , 991 , 992 , 994 , 995 , 996 , 999 , 1000 , 1001 , 1002 , 1003 , 1004 , 1005 , 1007 , 1011 , 1012 , 1015 , 1016 , 1017 , 1019 , 1022 , 1023 , 1027 , 1028 , 1029 , 1030 , 1031 , 1032 , 1033 , 1037 , 1040 , 1048 , 1049 , 1050 , 1052 , 1054 , 1056 , 1059 , 1061 , 1067 , 1068 , 1074 , 1075 , 1077 , 1078 , 1081 , 1082 , 1083 , 1088 , 1089 , 1090 , 1092 , 1093 , 1096 , 1099 , 1100 , 1103 , 1107 , 1108 , 1109 , 1140 , 1141 , 1143 , 1144 , 1145 , 1146 , 1147 , 1148 , 1149 , 1154 , 1155 ) , non-small cell lung cancer ( 28 , 29 , 30 , 31 , 32 , 33 , 40 , 41 , 42 , 43 , 44 , 45 , 51 , 53 , 112 , 167 , 197 , 199 , 314 , 357 , 358 , 374 , 375 , 387 , 388 , 389 , 390 , 418 , 419 , 422 , 437 , 443 , 463 , 469 , 470 , 495 , 509 , 527 , 528 , 558 , 559 , 560 , 567 , 568 , 569 , 570 , 571 , 611 , 612 , 613 , 657 , 658 , 659 , 679 , 680 , 681 , 685 , 686 , 687 , 691 , 692 , 704 , 705 , 706 , 707 , 708 , 715 , 716 , 717 , 718 , 719 , 720 , 721 , 722 , 723 , 724 , 725 , 726 , 727 , 728 , 729 , 730 , 731 , 732 , 733 , 734 , 735 , 738 , 740 , 741 , 742 , 795 , 809 , 810 , 811 , 812 , 813 , 815 , 829 , 830 , 851 , 854 , 855 , 856 , 857 , 859 , 860 , 862 , 873 , 874 , 875 , 878 , 885 , 887 , 914 , 915 , 916 , 917 , 922 , 923 , 928 , 929 , 932 , 940 , 943 , 944 , 946 , 947 , 948 , 951 , 956 , 968 , 971 , 977 , 978 , 979 , 980 , 986 , 987 , 988 , 989 , 990 , 991 , 992 , 994 , 995 , 996 , 999 , 1000 , 1001 , 1002 , 1003 , 1005 , 1007 , 1011 , 1012 , 1015 , 1016 , 1017 , 1019 , 1022 , 1027 , 1028 , 1029 , 1030 , 1031 , 1032 , 1033 , 1037 , 1040 , 1048 , 1052 , 1054 , 1056 , 1059 , 1061 , 1067 , 1074 , 1075 , 1077 , 1078 , 1082 , 1083 , 1089 , 1092 , 1093 , 1096 , 1099 , 1100 , 1107 , 1108 , 1109 , 1140 , 1141 , 1143 , 1144 , 1145 , 1146 , 1147 , 1148 , 1149 , 1154 , 1155 ) , non-small cell lung cancer, surrounding tissue ( 168 , 169 , 351 , 444 , 492 ) , non-small cell lung adenocarcinoma ( 30 , 31 , 32 , 33 , 42 , 43 , 44 , 45 , 51 , 53 , 112 , 185 , 197 , 199 , 357 , 387 , 388 , 389 , 390 , 422 , 443 , 469 , 470 , 509 , 527 , 528 , 685 , 686 , 687 , 692 , 706 , 707 , 708 , 759 , 760 , 764 , 784 , 785 , 848 , 849 , 1003 , 1022 , 1031 , 1074 , 1082 ) , non-small cell lung adenocarcinoma, surrounding tissue ( 52 , 193 , 194 , 195 , 196 , 198 , 200 , 201 , 438 ) , non-small cell large cell lung carcinoma ( 756 ) , non-small cell squamous cell lung carcinoma ( 185 , 305 , 308 , 309 , 310 , 313 , 316 , 357 , 391 , 392 , 393 , 394 , 471 , 472 , 944 , 977 , 989 , 1011 , 1012 , 1078 , 1146 , 1147 ) , small-cell lung cancer ( 950 , 1049 , 1050 , 1081 , 1088 , 1103 ) , lung cancer, surrounding tissue ( 59 , 60 , 61 , 95 , 157 , 159 , 161 , 162 , 434 , 435 ) , lymphoma ( 870 , 1104 , 1106 ) , B cell lymphoma ( 1104 , 1106 ) , Hodgkin's lymphoma ( 870 ) , neuroblastoma ( 110 , 111 , 769 , 770 , 771 , 788 , 789 , 790 , 833 , 834 , 835 , 871 , 926 , 933 , 942 , 945 ) , ovarian cancer ( 63 , 78 , 79 , 80 , 81 , 82 , 83 , 84 , 85 , 86 , 87 , 88 , 89 , 97 , 98 , 99 , 100 , 101 , 102 , 171 , 177 , 178 , 179 , 180 , 181 , 182 , 183 , 184 , 628 , 629 , 630 , 631 , 633 , 634 , 635 , 636 , 637 , 872 , 879 , 880 , 881 , 882 , 883 , 884 , 886 , 969 ) , ovarian epithelial carcinoma ( 63 , 79 , 84 ) , pancreatic cancer ( 1116 , 1117 , 1118 , 1123 , 1124 , 1127 , 1128 , 1134 , 1135 , 1142 , 1157 , 1158 ) , pancreatic carcinoma ( 1118 , 1127 , 1128 , 1134 , 1135 , 1142 ) , multiple myeloma ( 352 , 1006 ) , prostate cancer ( 1121 , 1150 , 1151 , 1152 ) , salivary gland cancer ( 414 ) , melanoma skin cancer ( 191 , 192 , 397 , 398 , 399 , 400 , 401 , 402 , 403 , 404 , 407 , 473 , 475 , 477 , 478 , 502 , 503 , 504 ) , non-melanoma skin cancer ( 1125 , 1126 , 1138 , 1139 ) , thymic carcinoma ( 56 ) , thyroid cancer ( 586 , 587 ) , ventricular tachycardia ( 57 , 58 , 64 , 65 , 66 , 67 , 68 , 69 , 70 , 71 ) , hypersplenism ( 577 )
Relevant cell line - cell type - tissue:
'liver, para-cholangiocellular carcinoma tissue' ( 73 ) , 143.98.2 (bone cell) ( 653 ) , 143B (bone cell) ( 624 ) , 184A1 (epithelial) ( 299 ) , 23132/87 (gastric) ( 865 ) , 293 (epithelial) [EFNB1 (human), transfection] ( 187 ) , 293 (epithelial) [EphB2 (human), transfection] ( 187 ) , 42-MG-BA (glial) ( 831 , 925 ) , 44-ZW-5409 (eye cell) ( 670 ) , 47-CD-3188 (glial) ( 667 ) , 56-DT-9110 (glial) ( 669 ) , 5637 (bladder cell) ( 806 ) , 639V (renal) ( 753 ) , 8-MG-BA (glial) ( 931 ) , A172 (glial) ( 905 , 906 , 1046 ) , A431 (epithelial) ( 1125 , 1126 , 1138 , 1139 ) , A498 (renal) ( 821 ) , A549 (pulmonary) [LKB1 (human), no information] ( 528 ) , A549 (pulmonary) ( 527 , 682 , 683 , 684 , 1068 , 1154 , 1155 ) , ACC-S (adenoidal) ( 446 , 448 ) , ACN ( 789 ) , AGS (gastric) ( 869 ) , AU565 (breast cell) ( 776 , 777 ) , AZ-521 (gastric) ( 579 ) , BC-3C (bladder cell) ( 754 ) , BEAS-2B (epithelial) [LKB1 (human), no information] ( 378 , 379 ) , BEAS-2B (epithelial) ( 376 , 377 ) , bladder ( 236 ) , brain ( 866 ) , breast ( 232 , 234 , 235 , 529 , 530 , 531 , 532 , 533 , 534 , 535 , 536 , 537 , 538 , 539 , 540 , 541 , 542 , 543 , 544 , 545 , 546 , 556 , 557 , 601 , 605 , 793 , 807 , 808 , 814 ) , BT-20 (breast cell) ( 677 , 678 ) , BT-474 (breast cell) ( 317 ) , BxPC-3 (pancreatic) ( 1116 , 1117 , 1123 , 1124 , 1157 , 1158 ) , Caki-2 (renal) ( 805 , 819 , 822 ) , Cal-12T (pulmonary) ( 956 ) , CAL-148 (breast cell) ( 838 ) , CAL-29 (bladder cell) ( 758 ) , CAL-51 (breast cell) ( 778 , 779 ) , CAL-85-1 (breast cell) ( 802 , 858 ) , Calu-3 (pulmonary) ( 1004 , 1090 ) , Caov-3 (ovarian) ( 886 ) , CAS-1 (glial) ( 768 ) , CCF-STTG1 (glial) ( 962 ) , cholangiocyte-liver ( 385 , 514 , 592 ) , CHP212 (neural crest) ( 926 ) , COLO-680N (esophageal) ( 153 , 841 , 894 ) , COLO-699 (pulmonary) ( 856 ) , COLO-704 (ovarian) ( 884 ) , colon ( 75 , 76 , 77 , 94 , 133 , 166 , 386 , 523 ) , CTV-1 (myeloid) ( 985 ) , DBTRG-05MG (glial) ( 974 ) , DK-MG (glial) ( 921 ) , DLD1 (intestinal) ( 166 ) , DMS153 (pulmonary) ( 1103 ) , DMS53 (pulmonary) ( 1050 ) , DMS79 (pulmonary) ( 1049 ) , DU 145 (prostate cell) ( 1151 , 1152 ) , EFM-19 (breast cell) ( 818 ) , EFM-192A (breast cell) ( 844 ) , EFO-21 (ovarian) ( 880 ) , EFO-27 (ovarian) ( 881 ) , EGI-1 (bile-duct cell) ( 474 ) , ELF-153 (megakaryocyte) ( 1055 ) , esophagus ( 311 , 312 , 315 , 322 , 323 , 324 , 325 , 326 , 327 , 328 , 329 , 330 , 331 , 332 , 333 , 334 , 335 , 336 , 337 , 338 , 339 , 340 , 341 , 342 , 343 , 344 , 345 , 346 , 347 , 348 , 350 ) , EVSA-T (breast cell) ( 852 ) , FU-OV-1 (ovarian) ( 872 ) , FU97 (gastric) ( 170 , 580 ) , G-292 (bone cell) ( 650 ) , GAMG (glial) ( 934 , 936 ) , GDM-1 (myeloid) ( 1026 ) , GI-CA-N (neural crest) ( 769 ) , GI-LI-N (neuron) ( 790 ) , GI-ME-N (neuron) ( 788 ) , GMS-10 (glial) ( 930 ) , GOS-3 (glial) ( 927 ) , HBEC3 (epithelial) [EGFR (human), transfection, EGFR (DelA746-A750)] ( 496 ) , HBEC3 (epithelial) [EGFR (human), transfection, EGFR (L858R)] ( 496 ) , HBEC3 (epithelial) [EGFR (human), transfection, EGFR (WT)] ( 496 ) , HBEC3 (epithelial) [KRas (human), transfection, K-Ras (G12V)] ( 496 ) , HCC1143 (breast cell) ( 967 ) , HCC1395 (breast cell) ( 952 ) , HCC1428 (breast cell) ( 966 ) , HCC15 (pulmonary) ( 878 , 885 ) , HCC1806 (breast cell) ( 976 ) , HCC1937 (breast cell) ( 963 ) , HCC202 (breast cell) ( 671 , 672 ) , HCC366 (pulmonary) ( 1054 ) , HCC38 (breast cell) ( 780 , 781 ) , HCC44 (pulmonary) ( 1033 ) , HCC70 (breast cell) ( 782 , 783 ) , HCC78 (pulmonary) ( 32 , 33 , 44 , 45 , 422 , 811 , 812 , 1032 ) , HCC827 (pulmonary) ( 112 , 685 , 686 , 687 , 706 , 707 , 708 , 1003 , 1074 , 1082 ) , HCT116 (intestinal) [PXN iso2 (human), homozygous knockout] ( 166 ) , HCT116 (intestinal) ( 34 , 35 , 46 , 47 , 166 , 712 , 816 , 1069 , 1070 , 1119 , 1120 , 1129 , 1130 ) , HCT15 (intestinal) ( 895 , 896 ) , HCT8 (intestinal) ( 897 , 898 ) , HD-MyZ (myeloid) ( 870 ) , HDQ-P1 (breast cell) ( 845 ) , heart ( 57 , 58 , 64 , 65 , 66 , 67 , 68 , 69 , 70 , 71 , 525 , 526 , 554 , 555 , 565 ) , HEK293T (epithelial) ( 166 , 1095 ) , HeLa (cervical) ( 174 , 175 , 412 , 413 , 488 , 497 , 638 , 998 ) , Hep 3B2.1-7 (hepatic) ( 428 ) , hepatic-'liver, para-cholangiocellular carcinoma tissue' ( 265 , 383 , 516 ) , hepatic-'liver, para-hepatocellular carcinoma tissue' ( 255 , 257 , 259 , 269 , 270 , 273 , 274 , 275 , 276 , 279 , 280 , 283 , 284 , 286 , 289 , 290 , 293 , 294 , 298 , 300 , 302 , 361 , 362 , 363 , 365 , 367 , 368 , 384 , 513 , 515 , 593 , 595 ) , hepatocyte-liver ( 256 , 258 , 266 , 267 , 268 , 271 , 272 , 277 , 278 , 281 , 282 , 285 , 287 , 288 , 292 , 295 , 296 , 301 , 359 , 360 , 366 , 370 , 510 , 594 ) , HepG2 (hepatic) ( 304 ) , HLE (hepatic) ( 372 ) , HLF (hepatic) ( 303 ) , HN5 (squamous) ( 1079 ) , HOS (bone cell) ( 623 ) , Hs766T (pancreatic) ( 1118 , 1142 ) , HT-29 (intestinal) ( 867 , 868 , 1024 , 1064 , 1065 , 1073 , 1131 , 1132 , 1133 ) , HuCCT1 (hepatic) ( 480 ) , Huh1 (hepatic) ( 373 ) , Huh28 (hepatic) ( 427 ) , Huh6 (hepatic) ( 484 ) , Huh7 (hepatic) ( 485 ) , HUVEC (endothelial) ( 450 , 451 , 452 , 453 , 454 , 455 , 456 , 457 , 1057 , 1058 ) , IM95 (gastric) ( 581 ) , intestine ( 1122 ) , J82 (bladder cell) ( 820 ) , JHH-1 (hepatic) ( 482 ) , JHH-2 (hepatic) ( 432 ) , JHH-4 (hepatic) ( 405 ) , JHH-5 (hepatic) ( 429 ) , JHH-6 (hepatic) ( 424 ) , JHH-7 (hepatic) ( 423 ) , JIMT-1 (breast cell) ( 803 , 853 ) , Jurkat (T lymphocyte) ( 3 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 54 , 55 , 74 , 91 , 92 , 93 , 96 , 103 , 104 , 106 , 107 , 108 , 109 , 114 , 115 , 118 , 123 , 124 , 125 , 126 , 127 , 128 , 129 , 130 , 131 , 134 , 135 , 136 , 137 , 138 , 140 , 141 , 142 , 143 , 144 , 154 , 155 , 156 , 163 , 164 , 176 , 186 , 207 , 208 , 209 , 213 , 225 , 226 , 227 , 228 , 229 , 230 , 231 , 238 , 239 , 240 , 241 , 245 , 246 , 247 , 248 , 249 , 250 , 251 , 254 , 260 , 261 , 262 , 263 , 264 , 306 , 307 , 353 , 354 , 382 , 395 , 416 , 417 , 420 , 433 , 500 , 501 , 505 , 506 , 507 , 508 , 511 , 517 , 591 , 602 , 603 , 604 , 610 , 614 , 615 , 616 , 627 , 662 , 663 , 664 , 665 , 666 , 688 , 689 , 690 , 693 , 699 , 743 , 972 , 983 , 984 , 1008 , 1009 , 1080 , 1087 , 1094 , 1097 , 1098 , 1110 , 1111 , 1112 , 1113 , 1114 , 1115 , 1165 , 1167 ) , K562 (erythroid) ( 72 , 116 , 117 , 158 , 160 , 172 , 188 , 189 , 190 , 206 , 233 , 396 , 553 , 588 , 606 , 608 , 609 , 649 , 654 , 655 , 694 , 695 , 696 , 697 , 698 , 702 , 703 , 710 , 713 , 714 , 792 , 817 , 888 , 889 , 892 , 893 , 899 , 957 , 958 , 959 , 960 , 961 , 997 , 1084 , 1153 , 1166 ) , KELLY (neural crest) ( 871 ) , kidney ( 237 , 242 , 243 , 244 , 252 , 253 , 625 , 626 ) , KPL-1 (breast cell) ( 861 ) , Kyse140 (esophageal) ( 796 , 797 , 910 , 911 ) , Kyse150 (esophageal) ( 146 , 828 ) , Kyse180 (esophageal) ( 152 , 912 ) , Kyse270 (esophageal) ( 149 , 824 , 825 , 826 , 827 , 902 ) , Kyse30 (esophageal) ( 145 , 908 ) , Kyse410 (esophageal) ( 913 ) , Kyse450 (squamous) ( 150 , 904 ) , Kyse510 (esophageal) ( 148 , 903 ) , Kyse520 (esophageal) ( 147 , 842 ) , Kyse70 (esophageal) ( 151 , 839 , 840 , 843 , 909 ) , LAN-1 (neural crest) ( 770 ) , LAN-5 (neural crest) ( 771 ) , LCLC-103H (pulmonary) ( 854 ) , liver ( 73 , 139 , 291 , 297 , 364 , 369 ) , LN18 (glial) ( 486 , 487 , 498 , 499 , 584 , 585 , 607 , 954 ) , LN229 (glial) ( 955 ) , LN405 (glial) ( 832 ) , LN444 (glial) ( 202 , 203 , 204 , 205 ) , LNCaP (prostate cell) ( 1150 ) , LOU-NH91 (squamous) ( 944 , 989 ) , lung ( 51 , 52 , 53 , 59 , 60 , 61 , 62 , 95 , 157 , 159 , 161 , 162 , 167 , 168 , 169 , 193 , 194 , 195 , 196 , 197 , 198 , 199 , 200 , 201 , 305 , 308 , 309 , 310 , 313 , 314 , 316 , 351 , 358 , 387 , 388 , 389 , 390 , 391 , 392 , 393 , 394 , 434 , 435 , 436 , 437 , 438 , 443 , 444 , 463 , 469 , 470 , 471 , 472 , 492 , 558 , 559 , 560 , 567 , 568 , 569 , 570 , 571 , 611 , 612 , 613 , 657 , 658 , 659 , 715 , 716 , 717 , 718 , 719 , 720 , 721 , 722 , 723 , 724 , 725 , 726 , 727 , 728 , 729 , 730 , 731 , 732 , 733 , 734 , 735 , 736 , 737 , 738 , 740 , 741 , 742 , 813 , 815 , 829 , 830 , 876 , 890 , 891 , 916 , 917 , 918 , 922 , 923 , 924 , 928 , 929 , 932 , 938 , 939 , 940 , 964 , 965 , 973 , 978 , 979 , 980 , 981 , 982 , 1015 , 1016 , 1017 , 1018 , 1019 , 1020 , 1021 , 1027 , 1037 , 1038 , 1039 , 1040 , 1051 , 1052 , 1053 , 1059 , 1060 , 1061 , 1062 , 1063 , 1071 ) , LXF-289 (pulmonary) ( 855 ) , M059J (glial) ( 953 ) , M059K (glial) ( 993 ) , MCAS (ovarian) ( 89 ) , MCF-10A (breast cell) [CSFR (human), transfection] ( 90 ) , MCF-10A (breast cell) ( 90 , 1041 , 1042 , 1085 , 1086 , 1101 , 1102 ) , MCF-7 (breast cell) ( 1035 , 1159 , 1160 ) , MDA-MB-361 (breast cell) ( 318 ) , MDA-MB-415 (breast cell) ( 673 , 674 ) , MDA-MB-435S (breast cell) ( 1044 ) , MDA-MB-436 (breast cell) ( 675 , 676 ) , MDA-MB-453 (breast cell) ( 1043 ) , MDA-MB-468 (breast cell) ( 1161 , 1162 , 1163 , 1164 ) , MDAH2774 (ovarian) ( 882 ) , ME-F2 (myeloid) ( 1010 ) , MG63 (bone cell) ( 622 ) , MHH-NB-11 (neural crest) ( 833 ) , MIA PaCa-2 (pancreatic) ( 1127 , 1128 ) , MKN-1 (gastric) ( 582 ) , MKN-45 (gastric) ( 1 , 2 , 4 , 5 , 6 , 7 , 23 , 24 , 25 , 26 , 27 , 36 , 37 , 48 , 49 , 105 , 119 , 120 , 121 , 122 , 173 , 185 , 441 , 442 , 709 , 711 ) , MKN-7 (gastric) ( 598 ) , MKN-74 (gastric) ( 599 ) , MNNG-HOS (bone cell) ( 1091 ) , MOLT-15 (myeloid) ( 1047 ) , MT-3 (breast cell) ( 784 , 785 ) , MUTZ-5 (B lymphocyte) ( 801 ) , myeloid-bone marrow ( 877 , 900 , 901 ) , N87 (gastric) ( 1072 ) , NCI-H1299 (pulmonary) ( 495 , 990 ) , NCI-H1355 (pulmonary) ( 847 ) , NCI-H1373 (pulmonary) ( 1140 ) , NCI-H1435 (pulmonary) ( 968 ) , NCI-H1437 (pulmonary) ( 1029 ) , NCI-H1563 (pulmonary) ( 971 ) , NCI-H1568 (pulmonary) ( 1028 ) , NCI-H1648 (pulmonary) ( 991 ) , NCI-H1650 (pulmonary) ( 28 , 29 , 40 , 41 , 987 , 988 , 1000 , 1096 , 1107 , 1156 ) , NCI-H1651 (pulmonary) ( 874 , 887 , 992 ) , NCI-H1666 (pulmonary) ( 1002 , 1089 , 1093 , 1109 ) , NCI-H1693 (pulmonary) ( 995 ) , NCI-H1703 (squamous) ( 185 , 319 , 320 , 321 , 357 , 425 , 426 , 679 , 680 , 681 , 1056 , 1141 ) , NCI-H1734 (pulmonary) ( 986 , 1092 ) , NCI-H1781 (pulmonary) ( 795 ) , NCI-H1792 (pulmonary) [LKB1 (human), no information] ( 374 , 375 ) , NCI-H1792 (pulmonary) ( 380 , 381 ) , NCI-H1793 (pulmonary) ( 996 ) , NCI-H1838 (pulmonary) ( 860 , 948 ) , NCI-H1869 (squamous) ( 977 ) , NCI-H1944 (pulmonary) ( 1022 , 1031 ) , NCI-H196 (pulmonary) ( 1081 , 1088 ) , NCI-H1975 (pulmonary) ( 1001 , 1099 , 1100 , 1108 ) , NCI-H1993 (pulmonary) ( 1077 ) , NCI-H2023 (pulmonary) ( 994 ) , NCI-H2030 (pulmonary) ( 951 ) , NCI-H2052 (pulmonary) ( 857 ) , NCI-H2066 (pulmonary) ( 915 ) , NCI-H2073 (pulmonary) ( 862 ) , NCI-H2085 (pulmonary) ( 914 ) , NCI-H2170 (squamous) ( 1078 ) , NCI-H2172 (pulmonary) ( 873 , 1007 ) , NCI-H2228 (pulmonary) ( 489 , 490 , 491 , 493 , 494 , 943 , 1048 ) , NCI-H226 (pulmonary) ( 1146 , 1147 ) , NCI-H2286 (pulmonary) ( 950 ) , NCI-H2342 (pulmonary) ( 859 ) , NCI-H2347 (pulmonary) ( 1075 ) , NCI-H2452 (pulmonary) ( 851 ) , NCI-H28 (pulmonary) ( 846 ) , NCI-H3122 (pulmonary) ( 30 , 31 , 42 , 43 , 509 ) , NCI-H3255 (pulmonary) ( 185 , 439 , 440 , 704 , 705 , 809 , 810 , 1005 , 1067 ) , NCI-H358 (pulmonary) [LKB1 (human), no information] ( 419 ) , NCI-H358 (pulmonary) ( 418 , 999 , 1083 ) , NCI-H441 (pulmonary) ( 1148 , 1149 ) , NCI-H460 (pulmonary) ( 1143 , 1144 , 1145 ) , NCI-H520 (squamous) ( 1011 , 1012 ) , NCI-H596 (pulmonary) ( 875 , 947 ) , NCI-H647 (pulmonary) ( 946 ) , NCI-H661 (pulmonary) ( 1023 ) , NCI-H838 (pulmonary) ( 1030 ) , NCI-H929 (B lymphocyte) ( 352 ) , NOMO-1 (myeloid) ( 1025 ) , NOZ ('epithelial, gallbladder') ( 430 ) , NT2 (testicular) ( 165 ) , NUGC-2 (gastric) ( 596 ) , NUGC-3 (gastric) ( 583 ) , NUGC-4 (gastric) ( 597 ) , OCI-ly12 (B lymphocyte) ( 1106 ) , OCI-ly3 (B lymphocyte) ( 1104 ) , OCUG-1 ( 481 ) , OPM-1 (B lymphocyte) ( 1006 ) , ovary ( 97 , 98 , 99 , 171 , 177 , 178 , 179 , 180 , 181 , 182 , 183 , 184 , 628 , 629 , 630 , 631 , 633 , 634 , 635 , 636 , 637 ) , OVISE (ovarian) ( 88 ) , OVKATE (ovarian) ( 78 , 80 , 87 ) , OVMANA (ovarian) ( 63 , 79 , 84 ) , OVMIU (ovarian) ( 82 ) , OVSAHO (ovarian) ( 81 , 101 ) , OZ (bile-duct cell) ( 431 ) , PA-1 (ovarian) ( 879 , 883 ) , PANC-1 (pancreatic) ( 1134 , 1135 ) , PC3 (prostate cell) ( 1121 ) , PC9 (pulmonary) ( 691 , 692 , 850 ) , PC9-IR (pulmonary) ( 759 , 760 , 848 , 849 ) , PC9-TAR (pulmonary) ( 764 ) , PLC/PRF/5 (hepatic) ( 371 ) , RERF-GC-1B (gastric) ( 578 ) , RKO (intestinal) ( 970 ) , RMG1 (ovarian) ( 86 , 102 ) , RMUG-S (ovarian) ( 85 ) , SACC-83 (salivary gland) ( 447 , 449 ) , salivary gland ( 414 , 415 ) , Scaber (squamous) ( 804 ) , SCH (gastric) ( 600 ) , SH-SY5Y (neural crest) ( 110 , 111 ) , SK-ES-1 ( 651 ) , SK-HEP-1 (endothelial) ( 356 , 547 ) , SK-N-MC (neural crest) ( 945 ) , SKBr3 (breast cell) ( 1036 ) , skin ( 132 , 191 , 192 , 397 , 398 , 399 , 400 , 401 , 402 , 403 , 404 , 407 , 473 , 475 , 477 , 478 , 502 , 503 , 504 ) , SKNAS (neural crest) ( 942 ) , SKNDZ (neural crest) ( 834 ) , SKNFI (neural crest) ( 835 ) , SKNSH (neural crest) ( 933 ) , SNB-19 (glial) ( 935 , 937 ) , SNU-1079 (hepatic) ( 409 ) , SNU-1196 (hepatic) ( 406 ) , SNU-182 (hepatic) ( 483 ) , SNU-308 (bile-duct cell) ( 410 ) , SNU-398 (hepatic) ( 408 ) , SNU-449 (hepatic) ( 355 ) , SNU-478 (bile-duct cell) ( 411 ) , SNU-5 (gastric) ( 794 ) , SNU-C2B (intestinal) ( 863 , 864 ) , spleen ( 577 ) , stomach ( 210 , 211 , 212 , 214 , 215 , 216 , 217 , 218 , 219 , 220 , 221 , 222 , 223 , 224 , 458 , 459 , 460 , 461 , 462 , 464 , 465 , 466 , 467 , 468 , 548 , 549 , 550 , 551 , 552 , 561 , 562 , 563 , 564 , 566 , 572 , 573 , 574 , 575 , 576 , 589 , 590 ) , SW1088 (glial) ( 941 ) , SW1710 (bladder cell) ( 757 ) , SW1783 (glial) ( 949 ) , SW480 (intestinal) ( 617 , 618 , 619 , 620 , 621 , 772 , 773 , 1013 ) , SW620 (intestinal) ( 739 , 774 , 775 , 823 , 919 , 920 , 1014 , 1136 , 1137 ) , SW780 (bladder cell) ( 755 ) , T1-73 (bone cell) ( 652 ) , T47D (breast cell) ( 1034 ) , T98G (glial) ( 975 ) , TFK-1 (bile-duct cell) ( 476 ) , thymus ( 56 ) , thyroid ( 586 , 587 ) , TYK-nu (ovarian) ( 83 , 100 ) , U-118MG (glial) ( 38 , 39 , 50 , 421 , 479 , 1066 ) , U-138 MG (glial) ( 836 ) , U87MG (glial) ( 656 , 1045 ) , UACC-812 (breast cell) ( 747 , 748 ) , UM-UC-1 (bladder cell) ( 837 ) , VACO432 (ovarian) ( 969 ) , ZR-75-30 (breast cell) ( 786 , 787 )

Upstream Regulation
Regulatory protein:
EGFR (human) ( 656 )
Putative upstream phosphatases:
PTPRT iso1 (human) ( 166 )
Phosphatases, in vitro:
PTPRT iso1 (human) ( 166 )
Treatments:
EGF ( 638 ) , ephrin_B2 ( 187 ) , gefitinib ( 185 ) , PDGF ( 166 ) , Su11274 ( 185 ) , VEGF ( 166 )

Downstream Regulation
Effects of modification on PXN iso2:
phosphorylation ( 166 )
Effects of modification on biological processes:
cell growth, altered ( 166 ) , cell motility, altered ( 166 ) , signaling pathway regulation ( 166 )

Disease / Diagnostics Relevance
Relevant diseases:
colorectal cancer ( 166 )

References 

1

Mulhern D (2011) CST Curation Set: 12645; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

2

Mulhern D (2011) CST Curation Set: 12855; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

3

Mulhern D (2011) CST Curation Set: 12644; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

4

Moritz A (2011) CST Curation Set: 12516; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

5

Moritz A (2011) CST Curation Set: 12517; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

6

Moritz A (2011) CST Curation Set: 12518; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

7

Moritz A (2011) CST Curation Set: 12519; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

8

Mulhern D (2011) CST Curation Set: 12473; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

9

Zhou J (2011) CST Curation Set: 12495; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

10

Zhou J (2011) CST Curation Set: 12496; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

11

Zhou J (2011) CST Curation Set: 12497; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

12

Zhou J (2011) CST Curation Set: 12342; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

13

Zhou J (2011) CST Curation Set: 12344; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

14

Zhou J (2011) CST Curation Set: 12346; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

15

Zhou J (2011) CST Curation Set: 12347; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

16

Zhou J (2011) CST Curation Set: 12348; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

17

Zhou J (2011) CST Curation Set: 12317; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

18

Zhou J (2011) CST Curation Set: 12318; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

19

Zhou J (2011) CST Curation Set: 12319; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

20

Zhou J (2011) CST Curation Set: 12320; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

21

Zhou J (2011) CST Curation Set: 12031; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY(YXXM) Antibodies Used to Purify Peptides prior to LCMS: Phospho-(Tyr) p85 PI3K Binding Motif Antibody Cat#: 3821
Curated Info

22

Zhou J (2011) CST Curation Set: 12033; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY(YXXM) Antibodies Used to Purify Peptides prior to LCMS: Phospho-(Tyr) p85 PI3K Binding Motif Antibody Cat#: 3821
Curated Info

23

Moritz A (2011) CST Curation Set: 12370; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

24

Moritz A (2011) CST Curation Set: 12371; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

25

Moritz A (2011) CST Curation Set: 12372; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

26

Moritz A (2011) CST Curation Set: 12373; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

27

Moritz A (2011) CST Curation Set: 12374; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

28

Possemato A (2011) CST Curation Set: 11905; Year: 2011; Biosample/Treatment: cell line, NCI-H1650/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

29

Possemato A (2011) CST Curation Set: 11906; Year: 2011; Biosample/Treatment: cell line, NCI-H1650/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

30

Possemato A (2011) CST Curation Set: 11907; Year: 2011; Biosample/Treatment: cell line, NCI-H3122/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

31

Possemato A (2011) CST Curation Set: 11908; Year: 2011; Biosample/Treatment: cell line, NCI-H3122/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

32

Possemato A (2011) CST Curation Set: 11909; Year: 2011; Biosample/Treatment: cell line, HCC78/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

33

Possemato A (2011) CST Curation Set: 11910; Year: 2011; Biosample/Treatment: cell line, HCC78/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

34

Possemato A (2011) CST Curation Set: 11911; Year: 2011; Biosample/Treatment: cell line, HCT116/untreated; Disease: colorectal carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

35

Possemato A (2011) CST Curation Set: 11912; Year: 2011; Biosample/Treatment: cell line, HCT116/untreated; Disease: colorectal carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

36

Possemato A (2011) CST Curation Set: 11913; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

37

Possemato A (2011) CST Curation Set: 11914; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

38

Possemato A (2011) CST Curation Set: 11915; Year: 2011; Biosample/Treatment: cell line, U118 MG/untreated; Disease: astrocytoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

39

Possemato A (2011) CST Curation Set: 11916; Year: 2011; Biosample/Treatment: cell line, U118 MG/untreated; Disease: astrocytoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

40

Possemato A (2011) CST Curation Set: 11917; Year: 2011; Biosample/Treatment: cell line, NCI-H1650/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

41

Possemato A (2011) CST Curation Set: 11918; Year: 2011; Biosample/Treatment: cell line, NCI-H1650/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

42

Possemato A (2011) CST Curation Set: 11919; Year: 2011; Biosample/Treatment: cell line, NCI-H3122/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

43

Possemato A (2011) CST Curation Set: 11920; Year: 2011; Biosample/Treatment: cell line, NCI-H3122/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

44

Possemato A (2011) CST Curation Set: 11921; Year: 2011; Biosample/Treatment: cell line, HCC78/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

45

Possemato A (2011) CST Curation Set: 11922; Year: 2011; Biosample/Treatment: cell line, HCC78/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

46

Possemato A (2011) CST Curation Set: 11923; Year: 2011; Biosample/Treatment: cell line, HCT116/untreated; Disease: colorectal carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

47

Possemato A (2011) CST Curation Set: 11924; Year: 2011; Biosample/Treatment: cell line, HCT116/untreated; Disease: colorectal carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

48

Possemato A (2011) CST Curation Set: 11925; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

49

Possemato A (2011) CST Curation Set: 11926; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

50

Possemato A (2011) CST Curation Set: 11927; Year: 2011; Biosample/Treatment: cell line, U118 MG/untreated; Disease: astrocytoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

51

Ren H (2011) CST Curation Set: 11785; Year: 2011; Biosample/Treatment: cell line, RP102/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

52

Ren H (2011) CST Curation Set: 11790; Year: 2011; Biosample/Treatment: cell line, FAC 13N/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

53

Ren H (2011) CST Curation Set: 11791; Year: 2011; Biosample/Treatment: cell line, FAC 13T/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

54

Possemato A (2011) CST Curation Set: 11711; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

55

Possemato A (2011) CST Curation Set: 11713; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

56

Li Y (2011) CST Curation Set: 10459; Year: 2011; Biosample/Treatment: tissue, thymus/untreated; Disease: thymic carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

57

Li Y (2011) CST Curation Set: 10523; Year: 2011; Biosample/Treatment: tissue, heart/untreated; Disease: ventricular tachycardia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

58

Li Y (2011) CST Curation Set: 10525; Year: 2011; Biosample/Treatment: tissue, heart/untreated; Disease: ventricular tachycardia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

59

Tucker M (2011) CST Curation Set: 10943; Year: 2011; Biosample/Treatment: tissue, lung/untreated; Disease: lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

60

Tucker M (2011) CST Curation Set: 10949; Year: 2011; Biosample/Treatment: tissue, lung/untreated; Disease: lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

61

Tucker M (2011) CST Curation Set: 10951; Year: 2011; Biosample/Treatment: tissue, lung/untreated; Disease: lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

62

Tucker M (2011) CST Curation Set: 10952; Year: 2011; Biosample/Treatment: tissue, lung/untreated; Disease: lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

63

Ren H (2011) CST Curation Set: 11303; Year: 2011; Biosample/Treatment: cell line, OVMANA/serum starved; Disease: ovarian epithelial carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

64

Li Y (2011) CST Curation Set: 10513; Year: 2011; Biosample/Treatment: tissue, heart/untreated; Disease: ventricular tachycardia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

65

Li Y (2011) CST Curation Set: 10438; Year: 2011; Biosample/Treatment: tissue, heart/untreated; Disease: ventricular tachycardia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

66

Li Y (2011) CST Curation Set: 10455; Year: 2011; Biosample/Treatment: tissue, heart/untreated; Disease: ventricular tachycardia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

67

Li Y (2011) CST Curation Set: 10450; Year: 2011; Biosample/Treatment: tissue, heart/untreated; Disease: ventricular tachycardia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

68

Li Y (2011) CST Curation Set: 10440; Year: 2011; Biosample/Treatment: tissue, heart/untreated; Disease: ventricular tachycardia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

69

Li Y (2011) CST Curation Set: 10501; Year: 2011; Biosample/Treatment: tissue, heart/untreated; Disease: ventricular tachycardia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

70

Li Y (2011) CST Curation Set: 10446; Year: 2011; Biosample/Treatment: tissue, heart/untreated; Disease: ventricular tachycardia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

71

Li Y (2011) CST Curation Set: 10436; Year: 2011; Biosample/Treatment: tissue, heart/untreated; Disease: ventricular tachycardia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

72

Moritz A (2011) CST Curation Set: 11310; Year: 2011; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

73

Gu TL, et al. (2011) Survey of tyrosine kinase signaling reveals ROS kinase fusions in human cholangiocarcinoma. PLoS One 6, e15640
21253578   Curated Info

74

Tucker M (2010) CST Curation Set: 10858; Year: 2010; Biosample/Treatment: cell line, Jurkat/pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

75

Tucker M (2010) CST Curation Set: 10853; Year: 2010; Biosample/Treatment: tissue, colon/untreated; Disease: colorectal cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

76

Tucker M (2010) CST Curation Set: 10857; Year: 2010; Biosample/Treatment: tissue, colon/untreated; Disease: colorectal cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

77

Tucker M (2010) CST Curation Set: 10854; Year: 2010; Biosample/Treatment: tissue, colon/untreated; Disease: colorectal cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

78

Ren H (2010) CST Curation Set: 10743; Year: 2010; Biosample/Treatment: cell line, OVKATE/serum starved; Disease: ovarian cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

79

Ren H (2010) CST Curation Set: 10744; Year: 2010; Biosample/Treatment: cell line, OVMANA/serum starved; Disease: ovarian epithelial carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

80

Ren H (2010) CST Curation Set: 10740; Year: 2010; Biosample/Treatment: cell line, OVKATE/serum starved; Disease: ovarian cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

81

Ren H (2010) CST Curation Set: 10752; Year: 2010; Biosample/Treatment: cell line, OVSAHO/serum starved; Disease: ovarian cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

82

Ren H (2010) CST Curation Set: 10754; Year: 2010; Biosample/Treatment: cell line, OVMIU/serum starved; Disease: ovarian cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

83

Ren H (2010) CST Curation Set: 10751; Year: 2010; Biosample/Treatment: cell line, TYK-nu/serum starved; Disease: ovarian cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

84

Ren H (2010) CST Curation Set: 10741; Year: 2010; Biosample/Treatment: cell line, OVMANA/serum starved; Disease: ovarian epithelial carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

85

Ren H (2010) CST Curation Set: 10742; Year: 2010; Biosample/Treatment: cell line, RMUG-S/serum starved; Disease: ovarian cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

86

Ren H (2010) CST Curation Set: 10749; Year: 2010; Biosample/Treatment: cell line, RMG1/serum starved; Disease: ovarian cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

87

Ren H (2010) CST Curation Set: 10748; Year: 2010; Biosample/Treatment: cell line, OVKATE/serum starved; Disease: ovarian cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

88

Ren H (2010) CST Curation Set: 10746; Year: 2010; Biosample/Treatment: cell line, OVISE/serum starved; Disease: ovarian cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

89

Ren H (2010) CST Curation Set: 10745; Year: 2010; Biosample/Treatment: cell line, MCAS/serum starved; Disease: ovarian cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

90

Knowlton ML, et al. (2010) Profiling Y561-Dependent and -Independent Substrates of CSF-1R in Epithelial Cells. PLoS One 5, e13587
21049007   Curated Info

91

Possemato A (2010) CST Curation Set: 10721; Year: 2010; Biosample/Treatment: cell line, Jurkat/pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

92

Possemato A (2010) CST Curation Set: 10538; Year: 2010; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

93

Possemato A (2010) CST Curation Set: 10537; Year: 2010; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

94

Tucker M (2010) CST Curation Set: 10310; Year: 2010; Biosample/Treatment: tissue, colon/untreated; Disease: colorectal cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

95

Tucker M (2010) CST Curation Set: 10314; Year: 2010; Biosample/Treatment: tissue, lung/untreated; Disease: lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

96

Tucker M (2010) CST Curation Set: 10319; Year: 2010; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

97

Ren H (2010) CST Curation Set: 10183; Year: 2010; Biosample/Treatment: tissue, ovary/untreated; Disease: ovarian cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411
Curated Info

98

Ren H (2010) CST Curation Set: 10178; Year: 2010; Biosample/Treatment: tissue, ovary/untreated; Disease: ovarian cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411
Curated Info

99

Ren H (2010) CST Curation Set: 10179; Year: 2010; Biosample/Treatment: tissue, ovary/untreated; Disease: ovarian cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411
Curated Info

100

Tucker M (2010) CST Curation Set: 10086; Year: 2010; Biosample/Treatment: cell line, TYK-nu/untreated; Disease: ovarian cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

101

Tucker M (2010) CST Curation Set: 10087; Year: 2010; Biosample/Treatment: cell line, OVSAHO/untreated; Disease: ovarian cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

102

Tucker M (2010) CST Curation Set: 10084; Year: 2010; Biosample/Treatment: cell line, RMG1/untreated; Disease: ovarian cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

103

Possemato A (2010) CST Curation Set: 10064; Year: 2010; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

104

Possemato A (2010) CST Curation Set: 10059; Year: 2010; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

105

Guo A (2010) CST Curation Set: 10131; Year: 2010; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

106

Possemato A (2010) CST Curation Set: 10062; Year: 2010; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

107

Possemato A (2010) CST Curation Set: 10060; Year: 2010; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

108

Possemato A (2010) CST Curation Set: 10063; Year: 2010; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

109

Possemato A (2010) CST Curation Set: 10061; Year: 2010; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

110

Rikova K (2010) CST Curation Set: 10078; Year: 2010; Biosample/Treatment: cell line, SH-SY5Y/inhibitor; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

111

Rikova K (2010) CST Curation Set: 10076; Year: 2010; Biosample/Treatment: cell line, SH-SY5Y/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

112

Rikova K (2010) CST Curation Set: 10028; Year: 2010; Biosample/Treatment: cell line, HCC827/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

113

Rikova K (2010) CST Curation Set: 10032; Year: 2010; Biosample/Treatment: cell line, DFCI HCC827 triple/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

114

Possemato A (2010) CST Curation Set: 9982; Year: 2010; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

115

Possemato A (2010) CST Curation Set: 9963; Year: 2010; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

116

Possemato A (2010) CST Curation Set: 9859; Year: 2010; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

117

Possemato A (2010) CST Curation Set: 9857; Year: 2010; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

118

Moritz A (2010) CST Curation Set: 9799; Year: 2010; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

119

Moritz A (2010) CST Curation Set: 9788; Year: 2010; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

120

Moritz A (2010) CST Curation Set: 9789; Year: 2010; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

121

Moritz A (2010) CST Curation Set: 9787; Year: 2010; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

122

Moritz A (2010) CST Curation Set: 9790; Year: 2010; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

123

Possemato A (2010) CST Curation Set: 9702; Year: 2010; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

124

Possemato A (2010) CST Curation Set: 9697; Year: 2010; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

125

Possemato A (2010) CST Curation Set: 9699; Year: 2010; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

126

Possemato A (2010) CST Curation Set: 9698; Year: 2010; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

127

Possemato A (2010) CST Curation Set: 9700; Year: 2010; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

128

Possemato A (2010) CST Curation Set: 9692; Year: 2010; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

129

Possemato A (2010) CST Curation Set: 9691; Year: 2010; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

130

Beausoleil S (2010) CST Curation Set: 9661; Year: 2010; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

131

Beausoleil S (2010) CST Curation Set: 9663; Year: 2010; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

132

Tucker M (2010) CST Curation Set: 9549; Year: 2010; Biosample/Treatment: tissue, skin/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

133

Tucker M (2010) CST Curation Set: 9504; Year: 2010; Biosample/Treatment: tissue, colon/untreated; Disease: colorectal cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

134

Possemato A (2010) CST Curation Set: 9564; Year: 2010; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

135

Possemato A (2010) CST Curation Set: 9569; Year: 2010; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

136